The ability of B cells and dendritic cells to present antigen increases during ontogeny

Journal of Immunology

Volumn 165, Issue 9, 2000, Pages 4803-4813

  Muthukkumar, S ^a   Goldstein, J ^a   Stein, K E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; B7 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN P 15095; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLYSACCHARIDE; TETANUS TOXOID;

ADOLESCENT; ANIMAL CELL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOREACTIVITY; MOUSE; NEISSERIA MENINGITIDIS; NEWBORN; NONHUMAN; ONTOGENY; PRIORITY JOURNAL;

EID: 0034326638     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.9.4803     Document Type: Article

References (67)

1. Human immunity to the meningococcus. I. The role of humoral Abs
2. Haemophilus influenzae type b capsular polysaccharide vaccine in children: A double-blind field of study of 100,000 vaccinees 3 mo to five years of age in Finland
3. Chemical studies on bacterial agglutination. VII. A quantitative study of the type specific and group specific Abs in antimeningococcal sera of various species and their relation to mouse protection
4. Immunity to disease caused by Hemophilus influenzae, type b. II. Specificity and some biological characteristics of 'natural' infection-acquired and immunization-induced Abs to the capsular polysaccharide of Hemophilus influenzae, type b
5. Protective capacity of Abs against Escherichia coli O and K Ags
6. Protection of mice from experimental infection with type III group B streptococcus using mAbs
7. Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b
8. Immune response of human infants to polysaccharide vaccines of group A and C Neisseria meningitidis
9. Interim report of controlled field trial of immunization with Hemophilus influenzae, type b and group C Neisseria meningitidis in Mecklenburg County, North Carolina (March 1974-March 1976)
10. Age-related response to two Hemophilus influenzae, type b vaccines
11. Serum Abs after vaccination with Haemophitus influenzae type b capsular polysaccharide and responses to reimmunization: No evidence of immunologic tolerance or memory
12. Epidemic disease due to serogroup C Neisseria meningitidis in SaoPaulo, Brazil
13. Prophylaxis against meningococcal disease
14. Clinical evaluation of group A and C meningococcal polysaccharide vaccines in infants
15. Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination
16. Chemo-immunological studies on conjugated carbohydrate-proteins. V. The immunological specificity of an Ag prepared by combining the capsular polysaccharide of type III pneumococcus with foreign protein
17. Glycoconjugate vaccines: What next?
18. Haemophilus influenzae type b infections are preventable everywhere
19. Ten years' experience with Haemophilus influenzae type b (Hib) conjugate vaccines in Finland
20. A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants
21. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory
22. Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine
23. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines
24. B and T cell immune responses to pneumococcal conjugate vaccines: Divergence between cartier and polysaccharide-specific immunogenicity
25. Thymus-independent and thymus-dependent responses to polysaccharide Ags
26. B lymphocyte heterogeneity: Development and characterization of alloantiserum which distinguishes B-lymphocyte differentiation alloantigens
27. Surface Ig D as a functional receptor for a subclass of B lymphocytes
28. + lymphocytes
29. 197 conjugate vaccine in 1 to 6-month infants
30. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIBTM): Clinical evaluation
31. Bone marrow and B cell differentiation
32. Anergy in immature B lymphocytes: Differential responses to receptor-mediated stimulation and T helper cells
33. Signaling through surface IgM in tolerance-susceptible immature murine B lymphocytes: Developmentally regulated differences in transmembrane signaling in splenic B cells from adult and neonatal mice
34. Immature B lymphocytes are deficient in expression of the src-family kinases p59fyn and p55fgr
35. The ontogeny of thymic independent Ab responses in vitro in normal mice and mice with X-linked B cell defect
36. B lymphocyte development and activation: Analysis with the mutant strain
37. Thymus independent Ags
38. Up-regulation of murine neonatal T helper cell responses by accessory cell factors
39. Newborn mice develop balanced Th1/Th2 primary effector responses in vivo but are biased to Th2 secondary responses
40. CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect the Th2 responses established by neonatal priming
41. CD40 ligation prevents neonatal induction of transplantation tolerance
42. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns
43. Dendritic cells in the T cell areas of lymphoid organs
44. Dendritic cells and the control of immunity
45. Ag-pulsed dendritic cells can efficiently induce an Ab response in vivo
46. + T cells
47. Neonatal dendritic cells
48. Neonatal murine B lymphocytes respond to polysaccharide Ags in the presence of IL-1 and IL-6
49. IL-12 enhances Ab responses to T-independent polysaccharide vaccines in the absence of T and NK cells
50. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates
51. T cell clones to two major T cell epitopes of myoglobin: Effect of I-A/I-E restriction on epitope dominance
52. Acid affects events leading to B ceil cycle entry
53. Enrichment of dendritic cells by plastic adherence and EA rosetting
54. Murine immune response to the Neisseria meningitidis, group C capsular polysacchafide I. Ontogeny
55. Protein-specific helper T-lymphocyte formation initiated by dendritic cells
56. The dendritic cell system and its role in immunogenicity
57. A quantitative analysis of APC function: Activated B cells stimulate naive CD4 T ceils but are inferior to dendritic cells in providing costimulation
58. Distinct features of dendritic cells and Ig activated B cells as stimulators of the primary mixed leukocyte reaction
59. + T cells in vitro: Characteristics and APC requirements
60. + T lymphocytes to peptide Ag in vivo
61. The role of CD28 receptor during T cells responses to Ag
62. Neonatal immuno-responsiveness
63. Ag presentation by neonatal murine spleen cells
64. Ag presentation for T cell IL-2 secretion is a late acquisition of neonatal B cells
65. Syk tyrosine kinase and B cell Ag receptor (BCR) Ig-α subunit determine BCR-mediated MHC class II-restricted Ag presentation
66. Defective regional immunity in the respiratory tract of neonates in attributable to hyporesponsiveness of local dendritic cells to activation signals
67. + T cells to protein Ags in vivo